TradingView
RocketTickers
Jul 31, 2020 5:20 PM
RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 St
Long
NASDAQ:RDHL
15
Redhill Biopharma Ltd.
NASDAQ
Description
⋅
Jul 31, 2020 5:20 PM
RDHL: RedHill Biopharma Ltd.
2020-07-31 07:00:10
RedHill Biopharma Announces FDA Clearance for Pivotal Phase 3 Study with RHB-204 for NTM Infections
Beyond Technical Analysis
More